Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Chie Sugimoto

4PUBLICATIONS

7CO-AUTHORS

Innate immunityTumour immunology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Feb 26, 2025

The Role of Mucosal-Associated Invariant T Cells in Viral Infections and Their Function in Vaccine Development.

Chie Sugimoto, Hiroshi Wakao

|Dec 23, 2022

Harnessing the Power of Mucosal-Associated Invariant T (MAIT) Cells in Cancer Cell Therapy.

Chie Sugimoto, Hiroyoshi Fujita, Hiroshi Wakao

|Apr 05, 2022

Reprogramming and redifferentiation of mucosal-associated invariant T cells reveal tumor inhibitory activity.

Chie Sugimoto, Yukie Murakami, Eisuke Ishii

|Aug 05, 2020

Protective Immune Responses Elicited by Deglycosylated Live-Attenuated Simian Immunodeficiency Virus Vaccine Are Associated with IL-15 Effector Functions.

Satoru Watanabe, Masayuki Fujino, Yohei Saito

Pageof 1

Frequent Collaborators

1 joint publications

Yohei Saito

1 joint publications

Hirotaka Sato

1 joint publications

Emi E Nakayama

1 joint publications

Aftab A Ansari

1 joint publications

Francois Villinger

1 joint publications

Kazuyasu Mori

1 joint publications

Hiroshi Wakao

Frequent Collaborators

1 joint publications

Yohei Saito

1 joint publications

Hirotaka Sato

1 joint publications

Emi E Nakayama

1 joint publications

Aftab A Ansari

Top Related Videos

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on : Aug 01, 2025

See more related videos

Top Related Videos

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on : Aug 01, 2025

See more related videos